2024 Annual Meeting | N3 - Neuroscience in the Clinic: Menopause: Why Does It Matter for Neurologic Disease?

Date Monday 04/15/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | 108/110/112

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Neuroscience in the Clinic Session

Director(s) Rashmi B. Halker Singh, MD, FAAN, Riley Bove, MD, FAAN

Topic(s) General Neurology, Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Cerebrovascular Disease and Interventional Neurology, Movement Disorders

Learning Objectives Participants should be able to articulate the major physiological changes that occur during the menopausal transition, as well as in the postmenopausal decades, including changes that arise both in nerves and glia, as well as in other systems (cardiovascular, immune, musculoskeletal) that can influence neurological functions. Participants should be able to explain the evidence of these changes, and their impact on perimenopausal and postmenopausal trajectories of brain health.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Systems-based Practice

Program Level Intermediate

Program Tracks Brain Health

Recommended Audience Fellow, General Neurologist, Specialist Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:40 PM MDT	Introduction	Introduction and Case Presentation Rashmi B. Halker Singh, MD, FAAN
03:40 PM - 04:10 PM MDT	Speaker	From Bench to Bedside...Menopause in Neuroinflammatory Disorders Riley Bove, MD, FAAN
04:10 PM - 04:20 PM MDT	Abstract	001 - Early-Onset Parkinson’s Disease in Women: A comparison of Hormonal Exposure with Late-Onset Parkinson’s Disease and Unaffected Controls Gaia Patane, MD
04:20 PM - 04:30 PM MDT	Abstract	002 - Prevalence of Female-Specific Risk Factors in Women with Ischemic and Hemorrhagic Stroke Victoria Rice, DO
04:30 PM - 05:00 PM MDT	Speaker	From Bench to Bedside...Menopause in Neurovascular Disorders Aleksandra Pikula, MD
05:00 PM - 05:30 PM MDT	Discussion	Discussion Rashmi B. Halker Singh, MD, FAAN, Riley Bove, MD, FAAN, Aleksandra Pikula, MD

Faculty Disclosures
Rashmi B. Halker Singh, MD, FAAN	Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Riley Bove, MD, FAAN	Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeurologyLive. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Roche Genentech. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Eli Lilly.
Aleksandra Pikula, MD	The institution of Dr. Pikula has received research support from CIHR.
Victoria Rice, DO	Dr. Rice has nothing to disclose.
Katy A. Helms, MD	Dr. Helms has nothing to disclose.
Cheryl Bushnell, MD, MHS	Dr. Bushnell has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ZZ Biotech. The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from AHRQ. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Amy K. Guzik, MD, FAAN	Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Sneha Lingam	Ms. Lingam has nothing to disclose.
Sierra Armstrong	No disclosure on file
Mia Guzynski	No disclosure on file
Gaia Patane, MD	Dr. Patane has nothing to disclose.
Aidan Mullan	No disclosure on file
Capucine Piat	Dr. Piat has nothing to disclose.
Pierpaolo Turcano, MD	Dr. Turcano has nothing to disclose.
Rodolfo Savica, MD, PhD, FAAN	The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.